Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study - Mar 16, 2021
NeoGenomics: Strong Growth Potential For Leader In Cancer Diagnostic Testing (NASDAQ:NEO) | Seeking Alpha
Lab testing giant, approaching $500M in revenue, welcomes new CEO | Business Observer
Neogenomics (NASDAQ:NEO) Stock Price News
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials | World Pharma Today
Pharma Services | NeoGenomics Laboratories
NeoGenomics establishes its European headquarters in Switzerland